PIM1 and acute lymphoblastic leukemia: Our gene profiling analysis identified a 58-gene signature that differed significantly between PIM inhibitor-sensitive versus -insensitive cell lines; this signature overlapped with the differential gene expression identified in ETP versus non-ETP ALL patients.